Joey CohenMedication Adherence
Paul TheisenPatient Acquisition
Brenda SnowAuthentic Patient Voice
Matt TurnerPatient Affordability
Bud BilanichSuccess Coach
Amy GilesIncreasing Engagement
Frank BurrellScientific Storytelling
Liz KaneImpactful Strategy
David LinetskyPoint-of-Care Marketing
Matthew DurhamOmnidynamic Marketing
Daniel SontupeMarket Access
Suma Ramadas, PhDMedical Affairs
Stacey GandlerBrand Nourishment
Pat PurcellMeeting Engagement
MADISON, Wis., June 06, 2017 (GLOBE NEWSWIRE) -- Cellectar Biosciences (Nasdaq:CLRB), an oncology-focused biotechnology ...
ALIS previously designated as an orphan drug, breakthrough therapy and Qualified Infectious Disease Product ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email